Saturday, October 31, 2026
Funding and security lead the morning: big raises and a chipmaker stepping into project finance, alongside new models and threats targeting code tools. A biotech experiment also put an AI agent in a live lab procedure, raising practical and ethical questions for researchers.
- Mistral publicly releases Large 4 for cybersecurity users
Mistral AI publicly released a model called Large 4. The release is explicitly targeted at cybersecurity users.
Why it matters: Security teams will get a new model tailored to their needs, which could change tooling choices for defensive workflows. - AI agent chose and injected gene therapy into live mouse
A biotech startup allowed an AI agent to select a gene therapy and perform a live injection into a mouse brain. The procedure successfully delivered the treatment.
Why it matters: The experiment shows AI agents can make and execute lab decisions, which matters for how research labs might operate and be governed. - OpenAI raises about $11 billion of $30 billion target
OpenAI raised roughly $11 billion in its latest funding round, far below its $30 billion target. The company's $1.25 trillion valuation also fell short of expectations as major investors pull back amid a recent tech sell-off, while rival Anthropic is pushing to go public as early as November.
Why it matters: The shortfall signals cooling investor appetite for large private AI rounds and may accelerate public-market plans for competitors. - Microsoft details Claude Code-branded extension with SSH backdoor
Microsoft reported on a malicious extension branded Claude Code that contains a persistent SSH backdoor. The analysis outlines how the extension maintains access.
Why it matters: Developers and security teams need to treat third-party code tools as potential attack vectors that can persistently compromise systems. - Nvidia may cosign loan for Nscale AI data center
Nvidia is weighing whether to act as a cosigner on a loan for Nscale’s AI data center project in West Virginia. The report notes that a chipmaker cosigning can help when investors are nervous about AI spending.
Why it matters: A cosign by a major supplier could lower financing risk for large AI infrastructure projects and influence who gets built. - Infisical raises $40 million to protect secrets from AI agents
Infisical raised $40 million with the stated goal of keeping company secrets safe from AI agents. The funding is aimed at securing sensitive data against agent-driven risks.
Why it matters: Investors are backing tooling focused on secrets management as AI agents become more common in workflows.